RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Aug. 12, 2024 |
|
| DisclosureLineElements [Line Items] | ||||
| Proceeds from common stock | $ 4,558,455 | $ 100,000 | ||
| Investment | 7,860,083 | 5,691,084 | ||
| Other investments | 7,023,583 | 5,691,084 | ||
| Board Of Directors [Member] | ||||
| DisclosureLineElements [Line Items] | ||||
| Accrued professional fees | 32,500 | |||
| AG Bio Life Capital I LP [Member] | ||||
| DisclosureLineElements [Line Items] | ||||
| Shares issued | 600,000 | |||
| Proceeds from common stock | $ 100,000 | |||
| Note receivable | $ 522,667 | |||
| Investment | $ 522,667 | $ 522,667 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of investments classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|